HEALTHEQUITY, INC.
For the period ended Jul 31, 2025. Filed Sep 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 2, 2025
HQY$102.11-1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial statements Condensed consolidated balance sheets as of July 31, 2025 (unaudited) and January 31, 2025
Part I. Financial information
Item 1. Financial statements
Condensed consolidated balance sheets
| (in thousands, except par value) | July 31, 2025 | January 31, 2025 |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $304,461 | $295,948 |
| Accounts receivable, net of allowance for doubtful accounts of $920 and $2,070 as of July 31, 2025 and January 31, 2025, respectively | 111,164 | 118,006 |
| Prepaid expenses and other current assets | 77,207 | 63,795 |
| Total current assets | 492,832 | 477,749 |
| Property and equipment, net | 3,088 | 3,239 |
| Operating lease right-of-use assets | 39,756 | 43,185 |
| Intangible assets, net | 1,152,456 | 1,204,658 |
| Goodwill | 1,648,145 | 1,648,145 |
| Other assets | 80,401 | 71,574 |
| Total assets | $3,416,678 | $3,448,550 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $9,600 | $14,361 |
| Accrued compensation | 32,482 | 69,330 |
| Accrued liabilities | 64,543 | 62,631 |
| Operating lease liabilities | 9,950 | 10,001 |
| Total current liabilities | 116,575 | 156,323 |
| Long-term liabilities | ||
| Long-term debt, net of issuance costs | 1,006,834 | 1,056,301 |
| Operating lease liabilities, non-current | 38,240 | 42,219 |
| Other long-term liabilities | 21,993 | 22,962 |
| Deferred tax liability | 86,615 | 55,834 |
| Total long-term liabilities | 1,153,682 | 1,177,316 |
| Total liabilities | 1,270,257 | 1,333,639 |
| Commitments and contingencies (see Note 5) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of July 31, 2025 and January 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value, 900,000 shares authorized, 86,421 and 86,536 shares issued and outstanding as of July 31, 2025 and January 31, 2025, respectively | 9 | 9 |
| Additional paid-in capital | 1,919,312 | 1,905,628 |
| Accumulated other comprehensive income | 203 | — |
| Accumulated earnings | 226,897 | 209,274 |
| Total stockholders’ equity | 2,146,421 | 2,114,911 |
| Total liabilities and stockholders’ equity | $3,416,678 | $3,448,550 |
-3-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.